NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447,351 | -23.1% | 36,370 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $581,413 | -16.3% | 36,180 | -9.4% | 0.00% | -50.0% |
| Q1 2023 | $695,007 | +88.4% | 39,920 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $368,861 | +7.2% | 39,920 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $344,000 | +5.8% | 39,920 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $325,000 | -33.0% | 39,920 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $485,000 | -64.4% | 39,900 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $1,361,000 | -29.3% | 39,900 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $1,925,000 | +6.8% | 39,900 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $1,802,000 | -0.2% | 39,900 | +6.5% | 0.00% | -25.0% |
| Q1 2021 | $1,806,000 | -8.7% | 37,450 | +2.0% | 0.00% | 0.0% |
| Q4 2020 | $1,978,000 | +46.7% | 36,730 | +0.5% | 0.00% | +33.3% |
| Q3 2020 | $1,348,000 | +21.3% | 36,530 | +1.8% | 0.00% | 0.0% |
| Q2 2020 | $1,111,000 | +12.2% | 35,870 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $990,000 | +44.5% | 35,870 | +53.2% | 0.00% | +50.0% |
| Q4 2019 | $685,000 | +58.2% | 23,410 | +3.4% | 0.00% | +100.0% |
| Q3 2019 | $433,000 | -12.9% | 22,650 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $497,000 | +26.5% | 22,650 | +18.0% | 0.00% | 0.0% |
| Q1 2019 | $393,000 | +62.4% | 19,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $242,000 | -76.8% | 19,200 | -71.8% | 0.00% | -66.7% |
| Q3 2018 | $1,044,000 | +17.0% | 68,034 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $892,000 | +515.2% | 68,034 | +282.0% | 0.00% | – |
| Q1 2018 | $145,000 | -8.2% | 17,810 | 0.0% | 0.00% | – |
| Q4 2017 | $158,000 | -20.2% | 17,810 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $198,000 | +23.8% | 17,810 | 0.0% | 0.00% | – |
| Q2 2017 | $160,000 | +13.5% | 17,810 | 0.0% | 0.00% | – |
| Q1 2017 | $141,000 | -7.8% | 17,810 | 0.0% | 0.00% | – |
| Q4 2016 | $153,000 | +4.8% | 17,810 | 0.0% | 0.00% | – |
| Q3 2016 | $146,000 | +2.1% | 17,810 | 0.0% | 0.00% | – |
| Q2 2016 | $143,000 | +20.2% | 17,810 | +1.1% | 0.00% | – |
| Q1 2016 | $119,000 | – | 17,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |